#US-based Biotechnology Company #Novavax's Protein-based Vaccine Has Shown Overall 90 Per ... - Latest Tweet by IANS Tweets

The latest Tweet by IANS Tweets states, '#US-based biotechnology company #Novavax's protein-based vaccine has shown overall 90 per cent efficacy against #Covid19. The vaccine NVX-CoV2373 is already being locally manufactured by the company's India partner Pune-based @SerumInstIndia under the brand name #Covovax.'

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)

Share Now